Suitability of a Self-report Questionnaire to Assess Adaptive Functioning for Persons With Intellectual Disability

October 11, 2023 updated by: Roel Kooijmans, Koraal

How to Improve the Possibilities for Self-reporting Adaptive Functioning for Persons With Mild Intellectual Disability or Borderline Intellectual Functioning With the ABAS-3?

In the proposed study, the investigators aim to investigate whether the existing ABAS-3 self-report questionnaire is suitable to be completed meaningfully by individuals who are perceived as having mild intellectual disability (55<IQ<85) based on cognitive impairment. Based on the participants' experiences and researchers' expertise, the investigators develop a 'more inclusive' self-report version. The investigators then look at the extent to which participants indicate that they understand this version better, based on user experiences and limited psychometric research. In doing so, the investigators also compare the outcomes of the self-report and informant-report variant.

Study Overview

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age 18 years or older
  • Last known Total Intelligence Quotient (TIQ) 55 - 85
  • Receiving support from a care organization for persons with ID.
  • A care worker who knows the participant for at least a year and knows him well enough tot complete the informant version of the ABAS-3 is available.

Exclusion Criteria:

• Severe physical or sensory impairment limiting ability to participate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
Persons with Mild Intellectual Disability (MID) or Borderline Intellectual Functioning (BIF) complete the ABAS-3 in assisted form on two occasions: the original version the first time and an adapted version after a few weeks.
A self-report questionnaire for assessing level of adaptive functioning
A self-report questionnaire for assessing level of adaptive functioning, adapted to the communication level of the participant

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Text comprehension - HyTeC T0
Time Frame: At baseline (T0)
Level of verbal understanding of instructions and questions in the ABAS-3 (Adaptive Behaviour Assessment System - Third Edition) questionnaire - results from HyTeC-cloze tests. The HyTeC-cloze (Hybrid Text Comprehension cloze) is a test to assess the level of text comprehension for a body of text.
At baseline (T0)
Text comprehension - HyTeC T1
Time Frame: Approximately 8 weeks after baseline (T1)
Level of verbal understanding of instructions and questions in an adapted version of the ABAS-3 (Adaptive Behaviour Assessment System - Third Edition) questionnaire - results from HyTeC-cloze tests. The HyTeC-cloze (Hybrid Text Comprehension cloze) is a test to assess the level of text comprehension for a body of text.
Approximately 8 weeks after baseline (T1)
Text comprehension - missings T0
Time Frame: At baseline (T0)
Level of verbal understanding of questions in the ABAS-3 (Adaptive Behaviour Assessment System - Third Edition) questionnaire. Outcomes are 1. number of missing (unscored) items (min 0 - max 30), 2. number of 'don't know' answers (min 0 - max 30) and 3. a composite score of 1 and 2.
At baseline (T0)
Text comprehension - missings T1
Time Frame: Approximately 8 weeks after baseline (T1)
Level of verbal understanding of questions in an adapted version of the ABAS-3 (Adaptive Behaviour Assessment System - Third Edition) questionnaire. Outcomes are 1. number of missing (unscored) items (min 0 - max 30), 2. number of 'don't know' answers (min 0 - max 30) and 3. a composite score of 1 and 2.
Approximately 8 weeks after baseline (T1)
Text comprehension - cognitive interviews T0
Time Frame: At baseline (T0)
Level of verbal understanding of questions in the questionnaire - qualitative analysis of answers from cognitive interviews during assessment of the ABAS-3 (Adaptive Behaviour Assessment System - Third Edition).
At baseline (T0)
Text comprehension - cognitive interviews T1
Time Frame: Approximately 8 weeks after baseline (T1)
Level of verbal understanding of questions in the questionnaire - qualitative analysis of answers from cognitive interviews during assessment of an adapted version of the ABAS-3 (Adaptive Behaviour Assessment System - Third Edition).
Approximately 8 weeks after baseline (T1)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported Adaptive Functioning - original ABAS-3 scores
Time Frame: At baseline (T0)
The ABAS-3 (Adaptive Behaviour Assessment System - Third Edition) is an observational scale that measures adaptive behaviour. Both self-report and informant report versions are available. In the context of the current study, a 30-item abbreviated version is used. Composite scores are calculated: a total score and three domain scores (conceptual, social and practical domain). Scores range from 0-90 for the total scale and 0-30 for each domain scale. Higher scores indicate better adaptive functioning.
At baseline (T0)
Self-reported Adaptive Functioning - adapted ABAS-3 scores
Time Frame: Approximately 8 weeks after baseline (T1)

The ABAS-3 (Adaptive Behaviour Assessment System - Third Edition) is an observational scale that measures adaptive behaviour. Both self-report and informant report versions are available. In the context of the current study, a 30-item abbreviated version is used. Composite scores are calculated: a total score and three domain scores (conceptual, social and practical domain). Scores range from 0-90 for the total scale and 0-30 for each domain scale. Higher scores indicate better adaptive functioning.

The second time participants complete the ABAS (approximately 8 weeks after baseline, T1), an adapted version is used, with language and design adapted to the comprehension level of participants according to the outcomes at baseline (T0).

Approximately 8 weeks after baseline (T1)
Informant-reported Adaptive Functioning - adapted ABAS-3 scores
Time Frame: Approximately 8 weeks after baseline (T1)

The ABAS-3 (Adaptive Behaviour Assessment System - Third Edition) is an observational scale that measures adaptive behaviour. Both self-report and informant report versions are available. In the context of the current study, a 30-item abbreviated version is used. Composite scores are calculated: a total score and three domain scores (conceptual, social and practical domain). Scores range from 0-90 for the total scale and 0-30 for each domain scale. Higher scores indicate better adaptive functioning.

For the informant-report an adapted version of the original is used; the adaptations for the self-report version are replicated for the informant version.

Approximately 8 weeks after baseline (T1)
Self-reported Adaptive functioning - SCAF
Time Frame: At baseline (T0)
The SCAF (Screener for Adaptive Functioning) is a screening questionnaire for adaptive functioning for individuals who may have MID or BIF. The SCAF yields a total AF score (min 0 - max 24), with higher scores indicating better adaptive functioning.
At baseline (T0)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Roel Kooijmans, MSc, Koraal

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Kooijmans, R., Mercera, G., Langdon, P. E., & Moonen, X. (2022). The adaptation of self-report measures to the needs of people with intellectual disabilities: A systematic review. Clinical Psychology: Science and Practice.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2023

Primary Completion (Estimated)

October 31, 2023

Study Completion (Estimated)

November 30, 2023

Study Registration Dates

First Submitted

March 15, 2023

First Submitted That Met QC Criteria

May 10, 2023

First Posted (Actual)

May 12, 2023

Study Record Updates

Last Update Posted (Actual)

October 12, 2023

Last Update Submitted That Met QC Criteria

October 11, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Study data are highly specific for this study and not relevant for sharing with other researchers, except for validation of results in exceptional circumstances. When required, relevant data will be made available upon request to reviewers or auditors, subject to privacy regulations. Only anonymized data will be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mild Intellectual Disability

Clinical Trials on Adaptive functioning self-report questionnaire

3
Subscribe